Aditya Bioinnovation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 1022.42%
- Ebitda 1022.16%
- Net Worth 76.06%
- Total Assets 552.35%
About Aditya Bioinnovation
Aditya Bioinnovation Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 September 2017 (Seven years and five months 17 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vibha Gupta, Surjyoti Bagchi, Archana Bagchi, and One other member serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC299532
- Company No.
299532
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aditya Bioinnovation?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Bagchi  | Director | 08-Sep-2017 | Current |
| Vibha Gupta | Director | 30-Mar-2023 | Current |
| Surjyoti Bagchi | Director | 10-Jan-2022 | Current |
| Aniruddha Bagchi | Director | 08-Sep-2017 | Current |
Financial Performance of Aditya Bioinnovation.
Aditya Bioinnovation Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1022.42% increase in profit. The company's net worth Soared by an impressive increase of 76.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aditya Bioinnovation?
Unlock access to Aditya Bioinnovation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aditya Bioinnovation?
Unlock and access historical data on people associated with Aditya Bioinnovation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aditya Bioinnovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditya Bioinnovation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
